fund
Artemis European Growth I
-
366.67p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
-
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
1.00% 0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
0.75%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
0.87%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
2.60%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
The objective of the fund is to achieve long-term capital growth through investment principally in companies in Europe (ex the UK). The fund invests across the capitalisation spectrum and has no restrictions by either industry or geographical split. The fund manager deploys the self-developed SmartGARP quantitative screen to identify stocks with the highest overall score across a number of factors. The process tends to perform best in directional markets but to underperform at market turning points.
Fund summary
| Sector | Europe Excluding UK |
| Structure | UNIT TRUST |
| Launched | |
| Size | £1m |
| Yield | 2.60% |
| Charging basis | Income |
| Dividends paid | Acc units only |
Charges
| Standard initial charge | 1.00% |
| Initial charge via Bestinvest | 0.00% |
| Annual management charge | 0.75% |
| Ongoing charges figure | 0.87% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
The SmartGARP quantitative model (Sentiment, Momentum, Accruals, Revisions, Top Down + Growth at a Reasonable Price) scans a universe of 2000 European Equities. The process gathers more than 100 pieces of stock specific data per company, 36 economic points and 28 separate sector weightings. This data is used to score the stocks in the universe, with the top ranked companies going into the portfolio. The process is normally 90% quantitative with the remainder coming from the manager, however he does have complete control over portfolio construction and an override where he thinks it is appropriate. 80% of performance is likely to come from stock selection, the remainder from sector selection. The investment process is designed to identify growing companies at a good price with a particular emphasis on earnings revisions, which is double weighted in the SmartGARP system.
Manager research
Average monthly relative returns
- 16/17 0.00%
- 17/18 0.00%
- 18/19 0.00%
- 19/20 0.00%
- 20/21 0.00%
Bestinvest MRI
- 3 years 0.00%
- 5 years 0.00%
- Career 0.00%
- 3 years 0.00%
- 5 years 0.00%
- Career 0.00%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Track record
Periods of worst performance
| Absolute | 0.00% () |
| Relative | 0.00% () |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Sector breakdown
| Pharmaceuticals | 10.00% |
| Building & Construction | 9.00% |
| Insurance | 9.00% |
| Banks | 8.00% |
| Life Insurance | 7.00% |
| Electricity Supply | 7.00% |
| Financials | 7.00% |
| Food & Drug Retailers | 6.00% |
| Travel | 4.00% |
| Oil & Gas Exploration & Production | 4.00% |
Portfolio
100-150 stocks, with the top 10 accounting for approximately a third of the fund
Key Investor Information